Licensing agreement for Convection Enhanced Delivery (CED) platform for use with GDNF - terminatedLicensing Agreement • May 26th, 2021
Contract Type FiledMay 26th, 2021MedGenesis has also granted Biovail a license to its Convection Enhanced Delivery (CED) platform for use with GDNF in CNS indications.
Licensing agreement for Convection Enhanced Delivery (CED) platform for use with GDNF - terminatedLicensing Agreement • May 26th, 2021
Contract Type FiledMay 26th, 2021MedGenesis has also granted Biovail a license to its Convection Enhanced Delivery (CED) platform for use with GDNF in CNS indications.
Licensing agreement for Convection Enhanced Delivery (CED) platform for use with GDNF - terminatedLicensing Agreement • May 26th, 2021
Contract Type FiledMay 26th, 2021MedGenesis has also granted Biovail a license to its Convection Enhanced Delivery (CED) platform for use with GDNF in CNS indications.
Licensing agreement for Convection Enhanced Delivery (CED) platform for use with GDNF - terminatedLicensing Agreement • May 26th, 2021
Contract Type FiledMay 26th, 2021MedGenesis has also granted Biovail a license to its Convection Enhanced Delivery (CED) platform for use with GDNF in CNS indications.
Licensing agreement for Convection Enhanced Delivery (CED) platform for use with GDNF - terminatedLicensing Agreement • May 26th, 2021
Contract Type FiledMay 26th, 2021MedGenesis has also granted Biovail a license to its Convection Enhanced Delivery (CED) platform for use with GDNF in CNS indications.
Licensing agreement for Convection Enhanced Delivery (CED) platform for use with GDNF - terminatedLicensing Agreement • May 26th, 2021
Contract Type FiledMay 26th, 2021MedGenesis has also granted Biovail a license to its Convection Enhanced Delivery (CED) platform for use with GDNF in CNS indications.